Bacteria-mediated disease therapy (Q37950232)

25 August 2017

title

Bacteria-mediated disease therapy (English)

1 reference

25 August 2017

Hao Yu

1

1 reference

25 August 2017

language of work or name

English

0 references

publication date

28 October 2011

1 reference

Applied Microbiology and Biotechnology

25 August 2017

published in

1 reference

25 August 2017

volume

92

1 reference

25 August 2017

issue

6

1 reference

25 August 2017

page(s)

1107-1113

1 reference

Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Bacteriolytic therapy can generate a potent immune response against experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Salmonella promoters preferentially activated inside tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Tumor-targeted Salmonella. Highly selective delivery vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Probiotics and severe acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

The promises and pitfalls of RNA-interference-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

A bacterial protein enhances the release and efficacy of liposomal cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Combination bacteriolytic therapy for the treatment of experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Monoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Anti-immunology: evasion of the host immune system by bacterial and viral pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Saccharomyces boulardii in maintenance treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Specific antibody-receptor interactions trigger InlAB-independent uptake of Listeria monocytogenes into tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Commensal host-bacterial relationships in the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

A lethal role for lipid A in Salmonella infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling (SOCS) expression and signaling in Helicobacter pylori infection: a novel mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Oral cytokine gene therapy against murine tumor using attenuated Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Bacteria in gene therapy: bactofection versus alternative gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Amelioration of oxidative stress with ensuing inflammation contributes to chemoprevention of H. pylori-associated gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Bacterial meningitis: pathogenesis, pathophysiology, and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Hijacking and exploitation of IL-10 by intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

The gut microbiota shapes intestinal immune responses during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Use of bacteria in anti-cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Approaches for the sequence-specific knockdown of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Pathways of T cell pathology in models of chronic intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Protective effects of Lactobacilli, Bifidobacteria and Staphylococci on the infection of cultured HT29 cells with different enterohemorrhagic Escherichia coli serotypes are strain-specific.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Prodrug converting enzyme gene delivery by L. monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Architecture of the Helicobacter pylori Cag-type IV secretion system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

An autologous oral DNA vaccine protects against murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Short hairpin RNA-expressing bacteria elicit RNA interference in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Attenuated Salmonella typhimurium carrying shRNA-expressing vectors elicit RNA interference in murine bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Antitumor therapeutic effects of a genetically engineered Salmonella typhimurium harboring TNF-α in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Ferredoxin is involved in secretion of cytotoxic necrotizing factor 1 across the cytoplasmic membrane in Escherichia coli K1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Identification and characterization of glnA promoter and its corresponding trans-regulatory protein GlnR in the rifamycin SV producing actinomycete, Amycolatopsis mediterranei U32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

A complex role of Amycolatopsis mediterranei GlnR in nitrogen metabolism and related antibiotics production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Mycobacterial strains that stimulate the immune system most efficiently as candidates for the treatment of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3648-X

10.1007/S00253-011-3648-X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference